Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Biogen Inc.
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
IPO Date: January 3, 1994
Sector: Healthcare
Industry: Biotech
Market Cap: $18.68B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.47 | 1.32%
Avg Daily Range (30 D): $1.79 | 1.39%
Avg Daily Range (90 D): $1.98 | 1.57%
Institutional Daily Volume
Avg Daily Volume: 2.08M
Avg Daily Volume (30 D): .91M
Avg Daily Volume (90 D): 1.16M
Trade Size
Avg Trade Size (Sh.): 108
Avg Trade Size (Sh.) (30 D): 36
Avg Trade Size (Sh.) (90 D): 39
Institutional Trades
Total Inst.Trades: 44,212
Avg Inst. Trade: $5.98M
Avg Inst. Trade (30 D): $11.35M
Avg Inst. Trade (90 D): $11.97M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 8
Market Closing Trades
Avg Closing Trade: $27.76M
Avg Closing Trade (30 D): $29.49M
Avg Closing Trade (90 D): $35.57M
Avg Closing Volume: 133.59K
   
News
Jul 21, 2025 @ 11:30 PM
Biogen to Highlight Scientific Progress Across Alz...
Source: Biogen Inc.
Jul 15, 2025 @ 8:00 AM
Draig Therapeutics Appoints Experienced Biotech Le...
Source: Mark Swallow, Sandi Greenwood
Jun 24, 2025 @ 5:00 PM
Multiple Sclerosis Clinical Trial Pipeline Shows P...
Source: Delveinsight
May 8, 2025 @ 2:00 PM
Medisafe PATHWAYS, Eisai and Biogen Recognized for...
Source: N/A
May 1, 2025 @ 6:46 PM
Biogen Beats Q1 Earnings Expectations As Two Newco...
Source: Vandana Singh
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $1.65 $2.67
Diluted EPS $1.64 $2.66
Revenue $ $ 2.43B $ 2.47B
Gross Profit $ $ 1.8B $ 1.83B
Net Income / Loss $ $ 240.5M $ 388.5M
Operating Income / Loss $ $ 311.2M $ 451M
Cost of Revenue $ $ 629.3M $ 638.7M
Net Cash Flow $ $ 223.3M $ -209.7M
PE Ratio    
Splits
Jan 18, 2001:   3:1